Qiagen NV | QIA - Loan Capital

Stock Price
34.91
Daily Change
-0.35 -0.98%
Monthly
-13.59%
Yearly
-4.51%
Q1 Forecast
35.13

Qiagen NV reported $1.65B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
argenx SE USD 35.57M 3.05M Jun/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Moderna USD 610M 584M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Revvity USD 2.63B 543K Dec/2025
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.48B 7M Dec/2025
Xeris Pharmaceuticals USD 220.33M 866K Dec/2025